HEADER PLANT PROTEIN 20-DEC-10 3Q2P TITLE REDUCED SWEETNESS OF A MONELLIN (MNEI) MUTANT RESULTS FROM INCREASED TITLE 2 PROTEIN FLEXIBILITY AND DISRUPTION OF A DISTANT POLY-(L-PROLINE) II TITLE 3 HELIX COMPND MOL_ID: 1; COMPND 2 MOLECULE: MONELLIN CHAIN B/MONELLIN CHAIN A CHIMERIC PROTEIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: MONELLIN CHAIN II, MONELLIN CHAIN I; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: DIOSCOREOPHYLLUM CUMMINSII; SOURCE 3 ORGANISM_COMMON: SERENDIPITY BERRY; SOURCE 4 ORGANISM_TAXID: 3457; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET22B KEYWDS SWEET PROTEIN, SWEET RECEPTOR, T1R2:T1R3, PLANT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR C.M.TEMPLETON,J.R.HOBBS,S.D.MUNGER,G.L.CONN REVDAT 4 13-SEP-23 3Q2P 1 REMARK SEQADV REVDAT 3 02-AUG-17 3Q2P 1 SOURCE REMARK REVDAT 2 22-JUN-11 3Q2P 1 JRNL REVDAT 1 06-APR-11 3Q2P 0 JRNL AUTH C.M.TEMPLETON,S.OSTOVAR POUR,J.R.HOBBS,E.W.BLANCH, JRNL AUTH 2 S.D.MUNGER,G.L.CONN JRNL TITL REDUCED SWEETNESS OF A MONELLIN (MNEI) MUTANT RESULTS FROM JRNL TITL 2 INCREASED PROTEIN FLEXIBILITY AND DISRUPTION OF A DISTANT JRNL TITL 3 POLY-(L-PROLINE) II HELIX. JRNL REF CHEM SENSES V. 36 425 2011 JRNL REFN ESSN 1464-3553 JRNL PMID 21343241 JRNL DOI 10.1093/CHEMSE/BJR007 REMARK 2 REMARK 2 RESOLUTION. 2.34 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.6.1_357) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.34 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.40 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 3 NUMBER OF REFLECTIONS : 16683 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 846 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 31.4028 - 4.2503 0.99 2733 137 0.1679 0.1911 REMARK 3 2 4.2503 - 3.3749 1.00 2697 153 0.1628 0.2172 REMARK 3 3 3.3749 - 2.9486 1.00 2713 140 0.1856 0.2622 REMARK 3 4 2.9486 - 2.6792 1.00 2674 146 0.2027 0.2733 REMARK 3 5 2.6792 - 2.4872 1.00 2712 150 0.2034 0.3194 REMARK 3 6 2.4872 - 2.3407 0.85 2308 120 0.1973 0.3119 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.33 REMARK 3 B_SOL : 31.62 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.350 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.23920 REMARK 3 B22 (A**2) : -0.79720 REMARK 3 B33 (A**2) : -0.44200 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.37660 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3285 REMARK 3 ANGLE : 1.037 4427 REMARK 3 CHIRALITY : 0.069 440 REMARK 3 PLANARITY : 0.005 582 REMARK 3 DIHEDRAL : 14.351 1276 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3Q2P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-JAN-11. REMARK 100 THE DEPOSITION ID IS D_1000063118. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-APR-08 REMARK 200 TEMPERATURE (KELVIN) : 200 REMARK 200 PH : 4.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16708 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.340 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 7.300 REMARK 200 R MERGE (I) : 0.10400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.34 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.8 REMARK 200 DATA REDUNDANCY IN SHELL : 5.50 REMARK 200 R MERGE FOR SHELL (I) : 0.53100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP (CCP4) REMARK 200 STARTING MODEL: PDB ENTRY 2O9U REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 200 MM NACL, 100 MM PHOSPHATE-CITRATE, REMARK 280 20% W/V PEG8000, PH 4.2, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 72.05000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 MET C 0 REMARK 465 MET D 0 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 50 CB CG CD OE1 OE2 REMARK 470 GLU C 50 CG CD OE1 OE2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU B 54 CD REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 35 -67.08 -105.09 REMARK 500 GLU A 50 -79.13 -119.11 REMARK 500 ARG A 53 75.08 46.55 REMARK 500 ASN B 35 -65.24 -105.82 REMARK 500 LYS B 36 147.20 -173.39 REMARK 500 ASP B 68 14.92 57.02 REMARK 500 LYS B 80 -73.90 -75.86 REMARK 500 ARG B 82 5.67 56.68 REMARK 500 ASN C 35 -70.68 -99.36 REMARK 500 ASN D 35 -91.99 -97.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY C 51 PHE C 52 -139.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3PYJ RELATED DB: PDB REMARK 900 MNEI-G16A SINGLE MUTANT REMARK 900 RELATED ID: 3PXM RELATED DB: PDB REMARK 900 MNEI-V37A SINGLE MUTANT REMARK 900 RELATED ID: 2O9U RELATED DB: PDB REMARK 900 WILD-TYPE MNEI DBREF 3Q2P A 1 50 UNP P02882 MONB_DIOCU 1 50 DBREF 3Q2P A 53 96 UNP P02881 MONA_DIOCU 2 45 DBREF 3Q2P B 1 50 UNP P02882 MONB_DIOCU 1 50 DBREF 3Q2P B 53 96 UNP P02881 MONA_DIOCU 2 45 DBREF 3Q2P C 1 50 UNP P02882 MONB_DIOCU 1 50 DBREF 3Q2P C 53 96 UNP P02881 MONA_DIOCU 2 45 DBREF 3Q2P D 1 50 UNP P02882 MONB_DIOCU 1 50 DBREF 3Q2P D 53 96 UNP P02881 MONA_DIOCU 2 45 SEQADV 3Q2P MET A 0 UNP P02882 INITIATING METHIONINE SEQADV 3Q2P ALA A 16 UNP P02882 GLY 16 ENGINEERED MUTATION SEQADV 3Q2P ALA A 37 UNP P02882 VAL 37 ENGINEERED MUTATION SEQADV 3Q2P ASN A 49 UNP P02882 GLU 49 CONFLICT SEQADV 3Q2P GLU A 50 UNP P02882 ASN 50 CONFLICT SEQADV 3Q2P GLY A 51 UNP P02882 LINKER SEQADV 3Q2P PHE A 52 UNP P02882 LINKER SEQADV 3Q2P MET B 0 UNP P02882 INITIATING METHIONINE SEQADV 3Q2P ALA B 16 UNP P02882 GLY 16 ENGINEERED MUTATION SEQADV 3Q2P ALA B 37 UNP P02882 VAL 37 ENGINEERED MUTATION SEQADV 3Q2P ASN B 49 UNP P02882 GLU 49 CONFLICT SEQADV 3Q2P GLU B 50 UNP P02882 ASN 50 CONFLICT SEQADV 3Q2P GLY B 51 UNP P02882 LINKER SEQADV 3Q2P PHE B 52 UNP P02882 LINKER SEQADV 3Q2P MET C 0 UNP P02882 INITIATING METHIONINE SEQADV 3Q2P ALA C 16 UNP P02882 GLY 16 ENGINEERED MUTATION SEQADV 3Q2P ALA C 37 UNP P02882 VAL 37 ENGINEERED MUTATION SEQADV 3Q2P ASN C 49 UNP P02882 GLU 49 CONFLICT SEQADV 3Q2P GLU C 50 UNP P02882 ASN 50 CONFLICT SEQADV 3Q2P GLY C 51 UNP P02882 LINKER SEQADV 3Q2P PHE C 52 UNP P02882 LINKER SEQADV 3Q2P MET D 0 UNP P02882 INITIATING METHIONINE SEQADV 3Q2P ALA D 16 UNP P02882 GLY 16 ENGINEERED MUTATION SEQADV 3Q2P ALA D 37 UNP P02882 VAL 37 ENGINEERED MUTATION SEQADV 3Q2P ASN D 49 UNP P02882 GLU 49 CONFLICT SEQADV 3Q2P GLU D 50 UNP P02882 ASN 50 CONFLICT SEQADV 3Q2P GLY D 51 UNP P02882 LINKER SEQADV 3Q2P PHE D 52 UNP P02882 LINKER SEQRES 1 A 97 MET GLY GLU TRP GLU ILE ILE ASP ILE GLY PRO PHE THR SEQRES 2 A 97 GLN ASN LEU ALA LYS PHE ALA VAL ASP GLU GLU ASN LYS SEQRES 3 A 97 ILE GLY GLN TYR GLY ARG LEU THR PHE ASN LYS ALA ILE SEQRES 4 A 97 ARG PRO CYS MET LYS LYS THR ILE TYR GLU ASN GLU GLY SEQRES 5 A 97 PHE ARG GLU ILE LYS GLY TYR GLU TYR GLN LEU TYR VAL SEQRES 6 A 97 TYR ALA SER ASP LYS LEU PHE ARG ALA ASP ILE SER GLU SEQRES 7 A 97 ASP TYR LYS THR ARG GLY ARG LYS LEU LEU ARG PHE ASN SEQRES 8 A 97 GLY PRO VAL PRO PRO PRO SEQRES 1 B 97 MET GLY GLU TRP GLU ILE ILE ASP ILE GLY PRO PHE THR SEQRES 2 B 97 GLN ASN LEU ALA LYS PHE ALA VAL ASP GLU GLU ASN LYS SEQRES 3 B 97 ILE GLY GLN TYR GLY ARG LEU THR PHE ASN LYS ALA ILE SEQRES 4 B 97 ARG PRO CYS MET LYS LYS THR ILE TYR GLU ASN GLU GLY SEQRES 5 B 97 PHE ARG GLU ILE LYS GLY TYR GLU TYR GLN LEU TYR VAL SEQRES 6 B 97 TYR ALA SER ASP LYS LEU PHE ARG ALA ASP ILE SER GLU SEQRES 7 B 97 ASP TYR LYS THR ARG GLY ARG LYS LEU LEU ARG PHE ASN SEQRES 8 B 97 GLY PRO VAL PRO PRO PRO SEQRES 1 C 97 MET GLY GLU TRP GLU ILE ILE ASP ILE GLY PRO PHE THR SEQRES 2 C 97 GLN ASN LEU ALA LYS PHE ALA VAL ASP GLU GLU ASN LYS SEQRES 3 C 97 ILE GLY GLN TYR GLY ARG LEU THR PHE ASN LYS ALA ILE SEQRES 4 C 97 ARG PRO CYS MET LYS LYS THR ILE TYR GLU ASN GLU GLY SEQRES 5 C 97 PHE ARG GLU ILE LYS GLY TYR GLU TYR GLN LEU TYR VAL SEQRES 6 C 97 TYR ALA SER ASP LYS LEU PHE ARG ALA ASP ILE SER GLU SEQRES 7 C 97 ASP TYR LYS THR ARG GLY ARG LYS LEU LEU ARG PHE ASN SEQRES 8 C 97 GLY PRO VAL PRO PRO PRO SEQRES 1 D 97 MET GLY GLU TRP GLU ILE ILE ASP ILE GLY PRO PHE THR SEQRES 2 D 97 GLN ASN LEU ALA LYS PHE ALA VAL ASP GLU GLU ASN LYS SEQRES 3 D 97 ILE GLY GLN TYR GLY ARG LEU THR PHE ASN LYS ALA ILE SEQRES 4 D 97 ARG PRO CYS MET LYS LYS THR ILE TYR GLU ASN GLU GLY SEQRES 5 D 97 PHE ARG GLU ILE LYS GLY TYR GLU TYR GLN LEU TYR VAL SEQRES 6 D 97 TYR ALA SER ASP LYS LEU PHE ARG ALA ASP ILE SER GLU SEQRES 7 D 97 ASP TYR LYS THR ARG GLY ARG LYS LEU LEU ARG PHE ASN SEQRES 8 D 97 GLY PRO VAL PRO PRO PRO HET NA A 97 1 HETNAM NA SODIUM ION FORMUL 5 NA NA 1+ FORMUL 6 HOH *202(H2 O) HELIX 1 1 GLY A 9 GLY A 27 1 19 HELIX 2 2 GLY B 9 GLY B 27 1 19 HELIX 3 3 GLY C 9 GLY C 27 1 19 HELIX 4 4 GLY D 9 GLY D 27 1 19 SHEET 1 A 5 GLU A 2 ILE A 6 0 SHEET 2 A 5 PHE A 34 TYR A 47 -1 O LYS A 43 N GLU A 4 SHEET 3 A 5 ILE A 55 ALA A 66 -1 O GLU A 59 N LYS A 44 SHEET 4 A 5 LYS A 69 ASP A 78 -1 O GLU A 77 N TYR A 58 SHEET 5 A 5 ARG A 84 ASN A 90 -1 O LEU A 87 N ASP A 74 SHEET 1 B 5 GLY B 1 ILE B 6 0 SHEET 2 B 5 PHE B 34 TYR B 47 -1 O LYS B 43 N GLU B 4 SHEET 3 B 5 ILE B 55 ALA B 66 -1 O GLU B 59 N LYS B 44 SHEET 4 B 5 LYS B 69 ASP B 78 -1 O ILE B 75 N TYR B 60 SHEET 5 B 5 ARG B 84 ASN B 90 -1 O ARG B 88 N ASP B 74 SHEET 1 C 5 TRP C 3 ILE C 6 0 SHEET 2 C 5 PHE C 34 TYR C 47 -1 O LYS C 43 N GLU C 4 SHEET 3 C 5 ILE C 55 ALA C 66 -1 O TYR C 65 N LYS C 36 SHEET 4 C 5 LEU C 70 ASP C 78 -1 O ILE C 75 N TYR C 60 SHEET 5 C 5 ARG C 84 ASN C 90 -1 O ARG C 88 N ASP C 74 SHEET 1 D 5 GLU D 2 ILE D 6 0 SHEET 2 D 5 PHE D 34 TYR D 47 -1 O LYS D 43 N GLU D 4 SHEET 3 D 5 ILE D 55 ALA D 66 -1 O TYR D 65 N LYS D 36 SHEET 4 D 5 LYS D 69 ASP D 78 -1 O PHE D 71 N VAL D 64 SHEET 5 D 5 ARG D 84 ASN D 90 -1 O ARG D 88 N ASP D 74 CISPEP 1 ARG A 39 PRO A 40 0 1.19 CISPEP 2 GLY A 91 PRO A 92 0 2.45 CISPEP 3 ARG B 39 PRO B 40 0 -2.11 CISPEP 4 GLY B 91 PRO B 92 0 1.96 CISPEP 5 ARG C 39 PRO C 40 0 -4.86 CISPEP 6 PHE C 52 ARG C 53 0 -22.51 CISPEP 7 GLY C 91 PRO C 92 0 0.68 CISPEP 8 ARG D 39 PRO D 40 0 -0.07 CISPEP 9 GLY D 91 PRO D 92 0 -0.86 CRYST1 31.400 144.100 45.800 90.00 90.00 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.031847 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006940 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021834 0.00000